HomeAI · summaries
Storia in 2 fonti
Organon shareholders approve Sun Pharma's $11.75-bn acquisition proposal
Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the proposed transaction closer to completion. Organon is expected to become a wholly owned subsidiary of Sun Pharma's US arm. The all-cash deal values Organon at an enterprise valuation of USD 11.75 billion. Regulatory approvals remain a key condition for the finalization of this merger.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Organon shareholders approve Sun Pharma's $11.75-bn acquisition proposal
Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the proposed transaction closer to completion.…
- ·
thehindubusinessline.com
Sun Pharma gets Organon shareholders’ nod for its $11.75-bn acquisition proposal
Organon shareholders approve Sun Pharma's $11.75 billion acquisition, paving the way for it to become a wholly owned subsidiary.